Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (201-210 of 519) with videos related to

Pageof 52
Sort By:
Blood|December 8, 2011
Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009Jan Sjöberg, Cat Halthur, Sigurdur Y Kristinsson, et al.
Haematologica|December 4, 2019
Fractures and survival in multiple myeloma: results from a population-based studySigrun Thorsteinsdottir, Gauti Gislason, Thor Aspelund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with MyelomaMattias Carlsten, Neha Korde, Ritesh Kotecha, et al.
Leukemia Research|January 25, 2023
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasmsJacob Jahn, Benjamin Diamond, Jeffrey Hsu, et al.
British Journal of Haematology|November 20, 2008
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004Graça M Dores, Ola Landgren, Katherine A McGlynn, et al.
Haematologica|March 24, 2018
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based studySigrun Thorsteinsdottir, Paul W Dickman, Ola Landgren, et al.
Blood Cancer Journal|May 25, 2026
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination SurveyShaji Kumar, David Murray, Dirk R Larson, et al.
Archives of Internal Medicine|February 25, 2009
Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infectionElizabeth Y Chiao, Eric A Engels, Jennifer R Kramer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 17, 2004
Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genesEmma Flordal Thelander, Sarah H Walsh, Mia Thorsélius, et al.
American Journal of Hematology|November 21, 2012
Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005Sigurdur Y Kristinsson, Sandra Eloranta, Paul W Dickman, et al.
Pageof 52

Showing results (201-210 of 519) with videos related to

Sort By:
Pageof 52
Blood|December 8, 2011
Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009Jan Sjöberg, Cat Halthur, Sigurdur Y Kristinsson, et al.
Haematologica|December 4, 2019
Fractures and survival in multiple myeloma: results from a population-based studySigrun Thorsteinsdottir, Gauti Gislason, Thor Aspelund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with MyelomaMattias Carlsten, Neha Korde, Ritesh Kotecha, et al.
Leukemia Research|January 25, 2023
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasmsJacob Jahn, Benjamin Diamond, Jeffrey Hsu, et al.
British Journal of Haematology|November 20, 2008
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004Graça M Dores, Ola Landgren, Katherine A McGlynn, et al.
Haematologica|March 24, 2018
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based studySigrun Thorsteinsdottir, Paul W Dickman, Ola Landgren, et al.
Blood Cancer Journal|May 25, 2026
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination SurveyShaji Kumar, David Murray, Dirk R Larson, et al.
Archives of Internal Medicine|February 25, 2009
Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infectionElizabeth Y Chiao, Eric A Engels, Jennifer R Kramer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 17, 2004
Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genesEmma Flordal Thelander, Sarah H Walsh, Mia Thorsélius, et al.
American Journal of Hematology|November 21, 2012
Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005Sigurdur Y Kristinsson, Sandra Eloranta, Paul W Dickman, et al.
Pageof 52